Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Syndax Pharmaceuticals Inc SNDX

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing pipeline of cancer therapies. Its product candidates include revumenib, and axatilimab. It is developing revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged also known as mixed lineage leukemia rearranged, acute... see more

Bullboard (NDAQ:SNDX)

View:
User Avatar Image
(9)
•••
  • MikeTesterX
Post by MikeTesteron Aug 01, 2024 3:49pm

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX): Poised for Trans

https://beyondspx.com/2024/08/01/syndax-pharmaceuticals-inc-nasdaqsndx-poised-for-transformative-growth-with-promising-pipeline-and-imminent-regulatory-approvals/
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Oct 05, 2021 8:30am

4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION!

$SNDX $MTEM $STRO $KRYS Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated ...more